HNOVA™ is applied across pharmaceutical, nutraceutical and cosmeceutical partners — anywhere an active needs to survive the journey to its target.
Scroll down for the detail behind each.
For pharma partners, HNOVA™ addresses problems conventional formulation struggles with: poor solubility, instability, and inefficient cellular uptake.
Conventional nutraceutical formats lose much of their active to poor solubility and digestive degradation.
HNOVA™ improves the stability of beauty-from-within ingredients and supports delivery of topical actives — the basis of the Lipologics dermaceutical portfolio: peptides, hyaluronic acid, ceramides, brightening and exfoliating actives..
For pharma partners, HNOVA™ addresses problems conventional formulation struggles with: poor solubility, instability, and inefficient cellular uptake. Hoynoza's broader platform work spans therapeutic areas from oncology to regenerative medicine.
Conventional nutraceutical formats lose much of their active to poor solubility and digestive degradation. HNOVA™ protects the payload and improves uptake — the basis of the Lipologics longevity, vitamin, carotenoid, metabolic-wellness and mineral portfolio.
HNOVA™ improves the stability of beauty-from-within ingredients and supports delivery of topical actives — the basis of the Lipologics dermaceutical portfolio: peptides, hyaluronic acid, ceramides, brightening and exfoliating actives.
The same HNOVA™ encapsulation principles, applied to different classes of active.
Signalling and structural peptides carried in a plant-based bilayer for improved stability and delivery.
Nucleic-acid payloads protected within a lipid carrier — the encapsulation principles behind gene-therapy and vaccine delivery.
Poorly soluble or unstable drug substances carried for improved solubility and bioavailability.
Botanical extracts and phytochemicals stabilised and made bioavailable in a liposomal carrier.
Mineral salts encapsulated for better tolerance and absorption than free-salt forms.
We learn your active, your format and your target market, and confirm whether a liposomal carrier fits.
HNOVA™ formulation development and characterisation on the Bengaluru campus.
Process transfer and scale-up toward GMP-grade batches, documented at each step.
Ingredient supply or technology transfer, with the technical documentation your regulatory files need.
From a ready ingredient to a fully custom, licensed programme.
Stock HNOVA™ liposomal ingredients from the 39+ active catalogue, documented for your formulation and regulatory files.
Formulation and characterisation of a liposomal version of your own active, developed alongside your team.
Process and know-how transfer, or out-licensing, for partners who want the platform closer to their own manufacturing.